BioSpace

Foghorn lays off 40% of staff after Lilly collaboration ends

Foghorn Therapeutics and Eli Lilly teamed up in 2021 to develop and commercialize oncology products. The biotech’s layoffs will leave the company with 65 employees as it refocuses on its proprietary portfolio programs.

By BioSpace

1 min read
Foghorn lays off 40% of staff after Lilly collaboration ends
Foghorn lays off 40% of staff after Lilly collaboration ends

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights